Fight Aging!

You may recall the epidemiological study indicating that populations at moderate altitude exhibit better long term health and a lower risk of age-related disease. The authors of that study suggested that this is because a greater level physical activity is involved in day to day activities in hilly regions, but this hypothesis is far from proven. Going beyond moderate elevation, we enter the realm of mild hypoxia as oxygen levels fall with increasing height above sea level. Interestingly, evidence suggests that intermittent mild hypoxia is beneficial, being one of the many forms of stress that cells react to with improved maintenance. Sustained mild hypoxia of the sort one achieves by living at a sufficiently high altitude is a different story, however.

In today's open access paper researchers report on a study of immune system characteristics and cell features in high altitude populations of the Tibetan plateau. Oxygen level is 20.9% at sea level. At 3500 meters, it is 13%. At 5000 meters it is 11%. There are small human populations living at around 5000 meters in Tibet, and their immune systems exhibit the downsides of a constant environment of mild hypoxia: greater chronic inflammation, and larger populations of various age-associated forms of T cell and B cell that are known to be harmful, for example. It is unknown as to the relative size of the contribution of altitude and its evident biochemical consequences versus socioeconomic factors to the comparatively low life expectancy in these high altitude populations, but these individuals certainly appear to exhibit accelerated immune aging, among other issues.

High altitude-mediated immune remodeling accelerates aging

High-altitude population (HAP) cohorts exhibit significantly reduced average lifespans compared to low-altitude population (LAP) cohorts, a pattern exemplified by Tibetans residing on the "Roof of the World," where life expectancy ranks much lower in China. As previously reported, populations chronically exposed to hypobaric hypoxia at high altitudes exhibit accelerated epigenetic aging, with the rate of epigenetic clock advancement positively correlating with residential altitude elevation. Notably, the Tuiwacun (TWC) (population of less than 160) in Tibet reports a median lifespan below 50 years, underscoring the proaging effects of high-altitude environments. While human diversity arises from molecular variations, these differences are not stochastic but rather reflect cellular adaptations to distinct environmental and lifestyle pressures, driving interpopulation heterogeneity.

High altitude mediates multifaceted physiological alterations that accelerate aging processes, driving organ functional decline, shifting in multidimensional aging-associated metrics, and ultimately elevating disease and mortality risks. Compared to LAP cohorts, HAP cohorts exhibit distinct gut microbiome profiles, genetic signatures, and transcriptional remodeling, reflecting evolutionary and environmental adaptations to chronic hypoxic stress. Long-term high-altitude residents may develop polycythemia to counteract hypobaric hypoxia; while this adaptation enhances oxygen-carrying capacity, it concurrently elevates blood viscosity, thereby increasing cardiac workload and thrombosis risk.

We present immune landscape characterization in human populations residing at 3656-meter (Lhasa) and 5070-meter (Tuiwacun) elevations on the Qinghai-Tibet Plateau, complemented by multiorgan single-cell RNA sequencing and spatially enhanced resolution omics sequencing (Stereo-seq) of mice under simulated 5000-meter hypoxic conditions. Comparative analysis revealed significantly elevated neutrophil proportions in high-altitude population (HAP) cohorts relative to low-altitude population cohorts. Notably, aging-associated immune cells (AICs) including exhausted T cells, age-associated B cells, and high-aging-score immune cells showed marked enrichment in HAP cohorts, a pattern conserved in mouse models. Stereo-seq analyses further identified coordinated niche interactions between AICs and aging-related intestinal epithelial cells, suggesting accelerated gut aging trajectories.